Pharmacokinetics and safety of bromotetrandrine (BrTet, W198) after single-dose intravenous administration in healthy Chinese volunteers.

MLA

Zheng, L., et al. “Pharmacokinetics and Safety of Bromotetrandrine (BrTet, W198) after Single-Dose Intravenous Administration in Healthy Chinese Volunteers.” Journal of Clinical Pharmacy & Therapeutics, vol. 35, no. 1, Feb. 2010, pp. 113–19. EBSCOhost, https://doi.org/10.1111/j.1365-2710.2009.01075.x.

APA

Zheng, L., Qing, Y. -p., Xu, N., Yu, Q., Wang, Y., Wang, F. -p., & Li, Z. -y. (2010). Pharmacokinetics and safety of bromotetrandrine (BrTet, W198) after single-dose intravenous administration in healthy Chinese volunteers. Journal of Clinical Pharmacy & Therapeutics, 35(1), 113–119. https://doi.org/10.1111/j.1365-2710.2009.01075.x

Chicago

Zheng, L., Y.-p. Qing, N. Xu, Q. Yu, Y. Wang, F.-p. Wang, and Z.-y. Li. 2010. “Pharmacokinetics and Safety of Bromotetrandrine (BrTet, W198) after Single-Dose Intravenous Administration in Healthy Chinese Volunteers.” Journal of Clinical Pharmacy & Therapeutics 35 (1): 113–19. doi:10.1111/j.1365-2710.2009.01075.x.